Combating COVID-19 – Monoclonal Antibody Therapies to Optimize Patient Care

Date: Friday, May 7, 2021

Description: A discussion and overview of the monoclonal antibody therapy program sponsored by the US Department of Health and Human Services.

Authors: 

Anderson, Michael R., MD, MBA, FAAP
Senior Advisor, Office of the Assistant Secretary of Preparedness and Response (ASPR)
US Dept. of Health and Human Services 

Chuk, Meredith, MD, FAAP
Lead, COVID-19 Therapeutics Team Office of the Assistant Secretary of Preparedness and Response (ASPR)
US Dept. of Health and Human Services 

Dugan, Vivien, PhD
Lead, Strain Surveillance and Emerging Variants Team, Laboratory & Testing Task Force, COVID-19 Emergency Response Team CDC 

Edward, Adolphe, DrHA, MBA, MSHA
Chief Executive Officer,
El Centro Regional Medical Center
El Centro, CA 

Kapoor, Hema, MD SM, D(ABMM)
Senior Medical Director
Infectious Diseases & Immunology and Global Diagnostics Network
Quest Diagnostics, Secaucus, New Jersey 

Ramers, Christian B., MD, MPH, AAHIVS
Chief, Population Health and Director, Graduate Medical Education Family Health Centers of San Diego